Cargando…

Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes

BACKGROUND: Dysglycemia at acute myocardial infarction (AMI) is common and is associated with mortality. Information on other outcomes is less well explored in patients without diabetes in a long‐term perspective. We aimed to explore the relationship between admission glucose level and long‐term out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ritsinger, Viveca, Hagström, Emil, Lagerqvist, Bo, Norhammar, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751923/ https://www.ncbi.nlm.nih.gov/pubmed/34719236 http://dx.doi.org/10.1161/JAHA.121.022667

Ejemplares similares

Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry
por: Ritsinger, Viveca, et al.
Publicado: (2020)

History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case–control study
por: Ritsinger, Viveca, et al.
Publicado: (2023)

Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data
por: Kristófi, Robin, et al.
Publicado: (2022)

Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
por: Meziani, Sara, et al.
Publicado: (2022)

The prognostic value of blood glucose level on admission in non-diabetic patients with acute myocardial infarction
por: Chioncel, V, et al.
Publicado: (2009)

Admission Glucose and In-hospital Mortality after Acute Myocardial Infarction in Patients with or without Diabetes: A Cross-sectional Study
por: Zhao, Shi, et al.
Publicado: (2017)

Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006–2019: a registry-based cohort study
por: Leosdottir, Margret, et al.
Publicado: (2023)

Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic
por: Wu, Jianhua, et al.
Publicado: (2021)

Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock
por: Yang, Jeong Hoon, et al.
Publicado: (2013)

Admission glucose level and short-term mortality in older patients with acute myocardial infarction: results from the KORA Myocardial Infarction Registry
por: Mamadjanov, Temur, et al.
Publicado: (2021)

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2017)

Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure
por: Lind, Viktor, et al.
Publicado: (2021)

Serum HMGB1 is a biomarker for acute myocardial infarction with or without heart failure
por: Wahid, Abdul, et al.
Publicado: (2023)

Androgen receptor polymorphism, testosterone levels, and prognosis in patients with acute myocardial infarction
por: Wang, Anne, et al.
Publicado: (2021)

Use of health and aged care services in Australia following hospital admission for myocardial infarction, stroke or heart failure
por: Hsu, Benjumin, et al.
Publicado: (2021)

IDF2022-0622 Mortality and cardiorenal disease in type 1 and type 2 diabetes after COVID-19 and influenza hospitalization in Sweden
por: Kristófl, R., et al.
Publicado: (2023)

Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction
por: Velders, Matthijs A., et al.
Publicado: (2019)

The Biomarkers for Acute Myocardial Infarction and Heart Failure
por: Wang, Xi-Ying, et al.
Publicado: (2020)

Macrophage Activities in Myocardial Infarction and Heart Failure
por: Duncan, Sophia Esi, et al.
Publicado: (2020)

Mechanism of heart failure after myocardial infarction
por: Jiang, Huaiyu, et al.
Publicado: (2023)

BNP and Admission Glucose as In-Hospital Mortality Predictors in Non-ST Elevation Myocardial Infarction
por: Takada, Julio Yoshio, et al.
Publicado: (2012)

Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c
por: Karayiannides, Stelios, et al.
Publicado: (2021)

Longitudinal Change in Fasting Blood Glucose and Myocardial Infarction Risk in a Population Without Diabetes
por: Jin, Cheng, et al.
Publicado: (2017)

ST-Elevation Myocardial Infarction, Thrombus Aspiration, and Different Invasive Strategies. A TASTE Trial Substudy
por: Fröbert, Ole, et al.
Publicado: (2015)

Association of peptidoglycan recognition protein 1 to post‐myocardial infarction and periodontal inflammation: A subgroup report from the PAROKRANK (Periodontal Disease and the Relation to Myocardial Infarction) study
por: Rathnayake, Nilminie, et al.
Publicado: (2022)

Immunopharmacology of Post-Myocardial Infarction and Heart Failure Medications
por: Panahi, Mona, et al.
Publicado: (2018)

The Intersection of Type 2 Myocardial Infarction and Heart Failure
por: McCarthy, Cian P., et al.
Publicado: (2021)

Heart failure after myocardial infarction: incidence and predictors
por: Jenča, Dominik, et al.
Publicado: (2020)

Heart Failure After Right Ventricular Myocardial Infarction
por: Nägele, Matthias P., et al.
Publicado: (2022)

Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus
por: Lucci, Claudia, et al.
Publicado: (2020)

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
por: Dondo, Tatendashe B., et al.
Publicado: (2017)

Impact of the COVID‐19 Pandemic on Patients Without COVID‐19 With Acute Myocardial Infarction and Heart Failure
por: Fox, Daniel K., et al.
Publicado: (2022)

Galectin-3 as a Prognostic Biomarker in Patients with First Acute Myocardial Infarction without Heart Failure
por: Vucic, Rada M., et al.
Publicado: (2023)

Impact of Admission Blood Glucose on Coronary Collateral Flow in Patients with ST-Elevation Myocardial Infarction
por: Kurmus, Ozge, et al.
Publicado: (2018)

The Impact of Different Plasma Glucose Levels on Heart Rate in Experimental Rats With Acute Myocardial Infarction
por: Pan, Guo-Zhong, et al.
Publicado: (2016)

Temporal Trends in Outcomes of ST-Elevation Myocardial Infarction Patients With Heart Failure and Diabetes
por: Ali, Bassem, et al.
Publicado: (2022)

Admission Glucose and Risk of Early Death in Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction: A Meta-Analysis
por: Zhao, Cheng-jin, et al.
Publicado: (2015)

The Effect of Admission Creatinine Levels on One-Year Mortality in Acute Myocardial Infarction
por: Cakar, Mehmet Akif, et al.
Publicado: (2012)

Myocardial Longitudinal Strain in Prediction of Heart Failure after Acute Myocardial Infarction
por: Chung, Hyemoon
Publicado: (2019)

Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction: A Nationwide Study
por: Velders, Matthijs A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ba4oeo1s4ufianteje4ljaebbc